BCYC Q1 2019 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$360M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+127.4% YoY

Gross Profit

$108,0001.7% margin

Operating Income

-$3M-51.6% margin

Net Income

-$7M-101.9% margin

EPS (Diluted)

$-0.37

QoQ Revenue Growth

+504.0%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$6M

Stock-Based Comp.

$276,000

Balance Sheet

Total Assets

$78M

Total Liabilities

$21M

Stockholders' Equity

$57M

Cash & Equivalents

$59M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$3M	+127.4%
Gross Profit	$108,000	-$901,000	+112.0%
Operating Income	-$3M	-$3M	-14.0%
Net Income	-$7M	-$3M	-156.6%